This Test Guideline describes a Rapid Estrogen ACTivity In Vivo (REACTIV) Assay in an aquatic assay that utilises transgenic Oryzias latipes (Japanese medaka) eleutheroembryos at day post hatch zero, in a multi-well plate format to identify chemicals active on the estrogen axis. The REACTIV assay was designed as a screening assay to provide a medium throughput and short-term assay to measure the response of eleutheroembryos to chemicals potentially active on the estrogen axis.
Test No. 252: Rapid Estrogen Activity In Vivo (REACTIV) assay
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
25 June 202511 Pages
-
25 June 202522 Pages
-
25 June 202524 Pages
-
Report25 June 202429 Pages
-
4 July 202353 Pages
Related publications
-
15 December 2025169 Pages
-
Report3 December 202594 Pages
-
30 June 2025193 Pages
-
Working paper30 June 2025250 Pages
-
30 June 2025329 Pages
-
Working paper30 June 2025270 Pages